Hepatocellular carcinoma: Western and Eastern surgeons’ points of view

Journal of Visceral Surgery

Volumn 149, Issue 5, 2012, Pages e302-e306

  Vibert, E ^a   Ishizawa, T ^b  

^a HÔPITAL PAUL BROUSSE   (France)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

France; Hepatocellular carcinoma; Japan; Liver function; Recurrence; Treatment

Indexed keywords

ARTICLE; CLINICAL PRACTICE; COMPARATIVE STUDY; CULTURAL FACTOR; FRANCE; HUMAN; JAPAN; LIVER CELL CARCINOMA; LIVER TUMOR; QUESTIONNAIRE;

CARCINOMA, HEPATOCELLULAR; CULTURAL CHARACTERISTICS; FRANCE; HUMANS; JAPAN; LIVER NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES;

MLCS; MLOWN;

EID: 84877137455     PISSN: 18787886     EISSN: 18787878     Source Type: Journal    
DOI: 10.1016/j.jviscsurg.2012.05.001     Document Type: Short Survey

References (34)

1. Bismuth, H., Chiche, L., Adam, R., Castaing, D., Diamond, T., Dennison, A., Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 218 (1993), 145–151.
2. Adam, R., Azoulay, D., Castaing, D., et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?. Ann Surg 238 (2003), 508–518.
3. Chan, A.C., Poon, R.T., Ng, K.K., Lo, C.M., Fan, S.T., Wong, J., Changing paradigm in the management of hepatocellular carcinoma improves the survival benefit of early detection by screening. Ann Surg 247 (2008), 666–673.
4. Eguchi, S., Kanematsu, T., Arii, S., et al. Recurrence-free survival more than 10 years after liver resection for hepatocellular carcinoma. Br J Surg 98 (2011), 552–557.
5. Fan, S.T., Mau Lo, C., Poon, R.T., et al. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann Surg 253 (2011), 745–758.
6. Clavien, P., Lesurtel, M., Bossuyt, P., Gores, G., Langer, B., Perrier, A., Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol 2045 (2012), 1–12.
7. Shi, M., Guo, R.P., Lin, X.J., et al. Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg 245 (2007), 36–43.
8. Boudjema, K., Cherqui, D., Carcinome hépatocellulaire. Arnette, (eds.) Monographie de l'Association Française de Chirurgie, 2006.
9. Aoki, T., Imamura, H., Hasegawa, K., et al. Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. Arch Surg 139 (2004), 766–774.
10. Pawlik, T.M., Poon, R.T., Abdalla, E.K., et al. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery 137 (2005), 403–410.
11. Kudo, M., Izumi, N., Kokudo, N., et al. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the Japan Society of Hepatology (JSH) 2010. Dig Dis 29 (2011), 339–364.
12. Ishizawa, T., Hasegawa, K., Aoki, T., et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 134 (2008), 1908–1916.
13. Hasegawa, K., Makuuchi, M., Takayama, T., et al. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol 49 (2008), 589–594.
14. Cucchetti, A., Ercolani, G., Vivarelli, M., et al. Is portal hypertension a contraindication to hepatic resection?. Ann Surg 250 (2009), 922–928.
15. Truant, S., Oberlin, O., Sergent, G., et al. Remnant liver volume to body weight ratio > or = 0.5%: a new cut-off to estimate postoperative risks after extended resection in non-cirrhotic liver. JACS 204 (2007), 22–33.
16. Azoulay, D., Castaing, D., Krissat, J., et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg 232 (2000), 665–672.
17. Makuuchi, M., Kosuge, T., Takayama, T., et al. Surgery for small liver cancers. Semin Surg Oncol 9 (1993), 298–304.
18. Llovet, J.M., Bru, C., Bruix, J., Prognosis of hepatocellular carcinoma: the BCLC staging classification. Sem in Liv Dis 19 (1999), 329–338.
19. Mise, Y., Hasegawa, K., Satou, S., et al. Venous reconstruction based on virtual liver resection to avoid congestion in the liver remnant. Br J Surg 98 (2011), 1742–1751.
20. Vibert, E., Azoulay, D., Hoti, E., et al. Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor. Am J Transpl 10 (2010), 129–137.
21. Bhangui, P., Vibert, E., Majno, P., et al. Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation. Hepatology 53 (2011), 1570–1579.
22. Roayaie, S., Bassi, D., Tarchi, P., Labow, D., Schwartz, M., Second hepatic resection for recurrent hepatocellular cancer: a Western experience. J Hepatol 55 (2011), 346–350.
23. Minagawa, M., Makuuchi, M., Takayama, T., Kokudo, N., Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 238 (2003), 703–710.
24. Yamashita, T., Ji, J., Budhu, A., et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 136 (2009), 1012–1024.
25. Roayaie, S., Blume, I.N., Thung, S.N., et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology 137 (2009), 850–855.
26. Fuks, D., Dokmak, S., Paradis, V., Diouf, M., Durand, F., Belghiti, J., Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis. Hepatology 55 (2012), 132–140.
27. Scatton, O., Zalinski, S., Terris, B., et al. Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation. Liver Transpl 14 (2008), 779–788.
28. Villanueva, A., Hoshida, Y., Battiston, C., et al. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology 140 (2011), 1501–1512.
29. Paradis, V., Zalinski, S., Chelbi, E., et al. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology 49 (2009), 851–859.
30. Nash, K.L., Woodall, T., Brown, A.S., Davies, S.E., Alexander, G.J., Hepatocellular carcinoma in patients with chronic hepatitis C virus infection without cirrhosis. World J Gastroenterol 16 (2010), 4061–4065.
31. Ding, B.S., Nolan, D.J., Butler, J.M., et al. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature 468 (2010), 310–315.
32. Ninomiya, M., Shirabe, K., Terashi, T., et al. Deceleration of regenerative response improves the outcome of rat with massive hepatectomy. Am J Transpl 10 (2010), 1580–1587.
33. Ishizawa, T., Bandai, Y., Ijichi, M., Kaneko, J., Hasegawa, K., Kokudo, N., Fluorescent cholangiography illuminating the biliary tree during laparoscopic cholecystectomy. Br J Surg 97 (2010), 1369–1377.
34. Ishizawa, T., Fukushima, N., Shibahara, J., et al. Real-time identification of liver cancers by using indocyanine green fluorescent imaging. Cancer 115 (2009), 2491–2504.